Inflammation and Uncoupling as Mechanisms of Periodontal Bone Loss
暂无分享,去创建一个
D. Graves | D. Cochran | J. Li
[1] A. Schmidt,et al. A murine model of accelerated periodontal disease in diabetes. , 2010, Journal of periodontal research.
[2] P. Bartold,et al. Mechanisms and control of pathologic bone loss in periodontitis. , 2010, Periodontology 2000.
[3] Yuuki Imai,et al. Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation , 2010, Journal of Bone and Mineral Metabolism.
[4] R. DePinho,et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. , 2010, The Journal of clinical investigation.
[5] E. Lewiecki,et al. Denosumab update , 2009, Current opinion in rheumatology.
[6] D. Burr,et al. Osteoblast Function Is Compromised at Sites of Focal Bone Erosion in Inflammatory Arthritis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] K. Guan,et al. Inhibition of Osteoblast Functions by IKK/NF-κB in Osteoporosis , 2009, Nature Medicine.
[8] Yu-cai Fu,et al. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. , 2009, Biochemical and biophysical research communications.
[9] D. Graves,et al. Activation of the Acquired Immune Response Reduces Coupled Bone Formation in Response to a Periodontal Pathogen1 , 2008, The Journal of Immunology.
[10] N. Sims,et al. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. , 2008, Seminars in cell & developmental biology.
[11] J. Cirelli,et al. AAV2/1-TNFR:Fc Gene Delivery Prevents Periodontal Disease Progression , 2008, Gene Therapy.
[12] D. Graves. Cytokines that promote periodontal tissue destruction. , 2008, Journal of periodontology.
[13] D. Cochran. Inflammation and bone loss in periodontal disease. , 2008, Journal of periodontology.
[14] T. E. Dyke,et al. The Management of Inflammation in Periodontal Disease , 2008 .
[15] K. Kirkwood,et al. A dominant function of p38 mitogen-activated protein kinase signaling in receptor activator of nuclear factor-kappaB ligand expression and osteoclastogenesis induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide. , 2008, Journal of periodontal research.
[16] G. Garlet,et al. The essential role of IFN-gamma in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. , 2008, Microbes and infection.
[17] H. Baker,et al. Beyond Good and Evil in the Oral Cavity: Insights into Host-Microbe Relationships Derived from Transcriptional Profiling of Gingival Cells , 2008, Journal of dental research.
[18] Takao Shimizu,et al. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. , 2008, Progress in lipid research.
[19] D. Graves,et al. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. , 2008, Journal of clinical periodontology.
[20] T. Kawai,et al. Interference with immune-cell-mediated bone resorption in periodontal disease. , 2007, Periodontology 2000.
[21] K. Kirkwood,et al. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. , 2007, Journal of periodontology.
[22] P. Kostenuik,et al. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. , 2007, Journal of periodontology.
[23] M. Yin,et al. Epidemiology, pathogenesis, and management of human immunodeficiency virus infection in patients with periodontal disease. , 2007, Periodontology 2000.
[24] R. Jilka. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. , 2007, Bone.
[25] S. Gaffen,et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. , 2007, Blood.
[26] G. Garlet,et al. Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease , 2007, Journal of dental research.
[27] J. Cirelli,et al. Novel host response therapeutic approaches to treat periodontal diseases. , 2007, Periodontology 2000.
[28] I. Ishikawa,et al. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. , 2007, Periodontology 2000.
[29] Georg Schett,et al. Dickkopf-1 is a master regulator of joint remodeling , 2007, Nature Medicine.
[30] M. Terauchi,et al. IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation , 2007 .
[31] G. Garlet,et al. The dual role of p55 tumour necrosis factor‐α receptor in Actinobacillus actinomycetemcomitans‐induced experimental periodontitis: host protection and tissue destruction , 2006, Clinical and experimental immunology.
[32] A. Togari,et al. Cytokine-induced nitric-oxide-dependent apoptosis in mouse osteoblastic cells: involvement of p38MAP kinase. , 2006, Archives of oral biology.
[33] Y. Izumi,et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. , 2006, The American journal of pathology.
[34] D. Graves,et al. Diabetes Enhances Periodontal Bone Loss through Enhanced Resorption and Diminished Bone Formation , 2006, Journal of dental research.
[35] S. Goldring,et al. Role of macrophages in LPS-induced osteoblast and PDL cell apoptosis. , 2006, Bone.
[36] R. Pacifici,et al. Estrogen Regulation of Immune Cell Bone Interactions , 2006, Annals of the New York Academy of Sciences.
[37] D. Graves,et al. Immunization Enhances Inflammation and Tissue Destruction in Response to Porphyromonas gingivalis , 2006, Infection and Immunity.
[38] Y. Teng. Protective and Destructive Immunity in the Periodontium: Part 2—T-cell-mediated Immunity in the Periodontium , 2006, Journal of dental research.
[39] B. Levy,et al. RvE1 protects from local inflammation and osteoclastmediated bone destruction in periodontitis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] D. Graves,et al. Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. , 2006, Diabetes.
[41] G. Garlet,et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. , 2006, Oral microbiology and immunology.
[42] T. Kawai,et al. Bacterial-Responsive B Lymphocytes Induce Periodontal Bone Resorption1 , 2006, The Journal of Immunology.
[43] Ashu Sharma,et al. Tannerella forsythia-induced Alveolar Bone Loss in Mice Involves Leucine-rich-repeat BspA Protein , 2005, Journal of dental research.
[44] J. Rubin,et al. The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. , 2005, American journal of physiology. Endocrinology and metabolism.
[45] D. Fine,et al. The Actinobacillus actinomycetemcomitans Autotransporter Adhesin Aae Exhibits Specificity for Buccal Epithelial Cells from Humans and Old World Primates , 2005, Infection and Immunity.
[46] Shi Wei,et al. IL-1 mediates TNF-induced osteoclastogenesis. , 2005, The Journal of clinical investigation.
[47] C. Clish,et al. Reduced Inflammation and Tissue Damage in Transgenic Rabbits Overexpressing 15-Lipoxygenase and Endogenous Anti-inflammatory Lipid Mediators 1 , 2003, The Journal of Immunology.
[48] J. Gunsolley,et al. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. , 2003, Annals of periodontology.
[49] B. Troen. Molecular mechanisms underlying osteoclast formation and activation , 2003, Experimental Gerontology.
[50] D. Fine,et al. Tight-adherence genes of Actinobacillus actinomycetemcomitans are required for virulence in a rat model , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[51] D. Graves,et al. Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. , 2002, The Journal of infectious diseases.
[52] G. Stein,et al. Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2αA) Is Inhibited by Tumor Necrosis Factor-α* , 2002, The Journal of Biological Chemistry.
[53] D. Graves,et al. Tumor Necrosis Factor Modulates Fibroblast Apoptosis, PMN Recruitment, and Osteoclast Formation in Response to P. gingivalis Infection , 2001, Journal of dental research.
[54] G. Huang,et al. Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[55] D. Graves,et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. , 2001, Journal of clinical periodontology.
[56] Yongwon Choi,et al. Osteoimmunology: Bone versus immune system , 2000, Nature.
[57] D. Roopenian,et al. Genetic Control of Susceptibility toPorphyromonas gingivalis-Induced Alveolar Bone Loss in Mice , 2000, Infection and Immunity.
[58] J. Penninger,et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. , 2000, The Journal of clinical investigation.
[59] S. Offenbacher,et al. Pharmacodynamic effects of ketoprofen on crevicular fluid prostanoids in adult periodontitis. , 2000, Journal of clinical periodontology.
[60] C. Clish,et al. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. , 2000, Biochemistry.
[61] D. Graves,et al. Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection. , 1999, The American journal of pathology.
[62] T. Nakashima,et al. Tumor necrosis factor-α and interleukin-1β increase the Fas-mediated apoptosis of human osteoblasts , 1999 .
[63] D. Roopenian,et al. CD4+ T Cells and the Proinflammatory Cytokines Gamma Interferon and Interleukin-6 Contribute to Alveolar Bone Loss in Mice , 1999, Infection and Immunity.
[64] D. Graves,et al. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. , 1998, Journal of periodontology.
[65] G. Ciliberto,et al. IL‐6 Mediates the Effects of IL‐1 or TNF, but Not PTHrP or 1,25(OH)2D3, on Osteoclast‐like Cell Formation in Normal Human Bone Marrow Cultures , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[66] D. Graves,et al. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. , 1998, Journal of immunology.
[67] O. Ljunggren,et al. Inflammatory cytokines regulate proliferation of cultured human osteoblasts. , 1997, Acta orthopaedica Scandinavica.
[68] W L Lin,et al. Differentiation of periodontal ligament fibroblasts into osteoblasts during socket healing after tooth extraction in the rat , 1994, The Anatomical record.
[69] D. Roopenian,et al. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. , 1994, Archives of oral biology.
[70] R. Page,et al. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates , 1994, Infection and immunity.
[71] R. Taichman,et al. Effects of interleukin-1β and tumor necrosis factor-α on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro , 1992, Inflammation.
[72] D. Kioussis,et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.
[73] M. Taubman,et al. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease , 1991, Infection and immunity.
[74] F. Dewhirst,et al. Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. , 1991, Lymphokine and cytokine research.
[75] E. Canalis,et al. Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. , 1988, Endocrinology.
[76] T. Bringman,et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.
[77] R. Williams,et al. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. , 1985, Science.
[78] I. Takazoe,et al. Oral implantation of Bacteroides asaccharolyticus and Eikenella corrodens in conventional hamsters , 1982, Infection and immunity.
[79] R. Page,et al. Current status of the host response in chronic marginal periodontitis. , 1981, Journal of periodontology.
[80] R. Kenworthy,et al. Studies of a periodontal tissue lesion in the rat, untreated or treated with chlorhexidine digluconate. , 1981, Journal of clinical periodontology.
[81] D. J. Rowe,et al. Quantitative analyses of osteoclasts, bone loss and inflammation in human periodontal disease. , 1981, Journal of periodontal research.
[82] N. Bissada,et al. Long term effect of systemic tetracycline administration on the severity of induced periodontitis in the rat. , 1979, Journal of periodontology.
[83] Schroeder He,et al. Pathogenesis of inflammatory periodontal disease. A summary of current work. , 1976 .
[84] H. Löe,et al. Plaque induced periodontal disease in beagle dogs. A 4-year clinical, roentgenographical and histometrical study. , 1975, Journal of periodontal research.
[85] H. M. Bohannan,et al. Oral debris, calculus, and periodontal disease in the beagle dog. , 1967, Periodontics.
[86] S. Rovin,et al. The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. , 1966, Journal of periodontal research.
[87] H. Löe,et al. Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation. , 1966, Journal of periodontal research.
[88] H. Löe,et al. EXPERIMENTAL GINGIVITIS IN MAN. , 1965, The Journal of periodontology.
[89] H. Jordan,et al. PERIODONTAL LESIONS IN THE SYRIAN HAMSTER. III. FINDINGS RELATED TO AN INFECTIOUS AND TRANSMISSIBLE COMPONENT. , 1964, Archives of oral biology.
[90] Anthony W. Gargiulo,et al. Dimensions and Relations of the Dentogingival Junction in Humans , 1961 .
[91] P. Keyes,et al. Periodontal lesions in the Syrian hamster. I. A method of evaluating alveolar bone resorption. , 1955, Oral surgery, oral medicine, and oral pathology.
[92] 広 高柳,et al. Osteoimmunology , 2013, Springer New York.
[93] A. De Rossi,et al. Interferon-gamma, interleukin-10, Intercellular adhesion molecule-1, and chemokine receptor 5, but not interleukin-4, attenuate the development of periapical lesions. , 2008, Journal of endodontics.
[94] Mariana Carolina Morales Chávez,et al. Periodontal disease associated to systemic genetic disorders. , 2007, Medicina oral, patologia oral y cirugia bucal.
[95] M. Terauchi,et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. , 2007, The Journal of clinical investigation.
[96] M. Somerman,et al. Advances in defining regulators of cementum development and periodontal regeneration. , 2007, Current topics in developmental biology.
[97] G. Stein,et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. , 2002, The Journal of biological chemistry.
[98] W. Ries,et al. Characterization of interferon gamma receptors on osteoclasts: Effect of interferon gamma on osteoclastic superoxide generation , 2002, Journal of cellular biochemistry.
[99] M. Nanes,et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. , 2000, Endocrinology.
[100] T. Nakashima,et al. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. , 1999, The Journal of laboratory and clinical medicine.
[101] D. Graves,et al. Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingiva. , 1995, Journal of periodontology.
[102] R. Taichman,et al. Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro. , 1992, Inflammation.
[103] F. Dewhirst,et al. Interleukin-1 beta is a potent inhibitor of bone formation in vitro. , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[104] A. Parfitt. The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. , 1982, Metabolic bone disease & related research.
[105] J. Lindhe,et al. Conditions and pathological features of rapidly destructive, experimental periodontitis in dogs. , 1980, Journal of periodontology.
[106] R. Page,et al. Pathogenesis of inflammatory periodontal disease. A summary of current work. , 1976, Laboratory investigation; a journal of technical methods and pathology.
[107] Rongkun Liu,et al. Tumor Necrosis Factor- (cid:1) Mediates Diabetes-Enhanced Apoptosis of Matrix-Producing Cells and Impairs Diabetic Healing , 2006 .